Synthetic Biologist Aims to Create Pig with Human Lungs
By Lisa M. Krieger,
San Jose Mercury News
| 11. 14. 2014
Untitled Document
SAN FRANCISCO -- In a provocative cross-species experiment, scientists are striving to rewrite the pig genome so the animal grows lungs that could be transplanted into humans.
"We are re-engineering the pig, changing its genetic code," said genome pioneer Craig Venter at SynBioBeta 2014, an annual synthetic biology conference in San Francisco. "If we succeed with rewriting the pig genome, we will have replacement organs for those who need them," he said Friday.
His team at Synthetic Genomics is designing the project, he said, creating on computers the code needed to build the hybrid. By changing as few as five genes, they have created lungs that survived for a year in baboons, he said.
In other major news at the conference, Google confirmed that Stanford University bioengineer Drew Endy has joined its team at the secretive Google X, which created such projects as Google Glass, driverless cars and high-altitude Wi-Fi balloons.
The hiring of Endy, brought to Stanford's School of Engineering from the Massachusetts Institute of Technology, suggests that Google seeks to explore the design and construction of...
Related Articles
By Parmy Olson, Bloomberg Opinion | 07.12.2024
Photo from Hubert Burda Media via Flickr licensed under CC by NC-SA 2.0
Peter Thiel’s Enhanced Games promise to be an annual sporting event that lets athletes use performance-enhancing drugs, nicknamed the pro-doping Olympics (which some would scoff isn’t all...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Eva Roytburg, Fortune | 07.11.2024
By Sarah Kliff and Azeen Ghorayshi, The New York Times | 07.15.2024